Hepatitis delta antigen (HDAg) consists of two species, large (LHDAg) and small (SHDAg), which are identical in sequence except that the large form contains 19 extra amino acids at the C terminus. The large form is prenylated on the Cxxx motif. The small form can trans activate HDV RNA replication, while the large form inhibits it. To determine the molecular basis for their differential functions, we examined the effects of prenylation on the conformation and function of HDAg. We show that the presence of prenylates masks a conformational epitope which is present in SHDAg but hidden in wild-type LHDAg; this epitope becomes exposed in all of the nonprenylated mutant LHDAgs. Prenylation also plays a major role in conferring the trans-dominant negative inhibitory activity of LHDAg, since the loss of prenylation in LHDAg reduced its inhibitory activity. The primary amino acids of the C-terminal sequence also contributed to the maintenance of the HDAg protein conformation; a prenylated LHDAg mutant with a five-amino-acid deletion had an exposed C-terminal epitope. By examining LHDAg mutants which have deletions of various extents of C-terminal sequence, with or without the prenylation motif, we have further shown that all of the prenylated mutants have much higher levels of trans-dominant suppressor activities than do the corresponding nonprenylated mutants. Surprisingly, a few nonprenylated LHDAg mutants were able to trans activate HDV RNA replication, while all of the prenylated ones lost this function. These results suggest that isoprenylates cause the masking of a conformational epitope of HDAg and that conformational differences between the large and small HDAgs account for the differences in their trans-activating and trans-dominant inhibitory biological activities.
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Hepatitis delta virus (HDV) is a defective RNA virus which contains a 1.7-kb single-stranded circular genome (16, 25, 35) . HDV RNA is known to replicate by RNA-dependent RNA synthesis via a rolling-circle mechanism (24) and has autocatalytic cleavage and ligation activities (32, 33, 37, 38) . The viral RNA encodes only a single protein, hepatitis delta antigen (HDAg), from the antigenomic strand. During RNA replication, an RNA editing event occurs at the amber termination codon for HDAg, resulting in the synthesis of a larger isoform of HDAg (21) . These two species of HDAg, small HDAg (SHDAg) of 24 kDa (195 amino acids) and large HDAg (LHDAg) of 27 kDa (214 amino acids), are identical in sequence except that LHDAg contains 19 additional amino acids at its C terminus (36) . However, the two HDAg forms have entirely different functions: SHDAg trans activates HDV RNA replication (17) , whereas LHDAg inhibits HDV RNA replication (3) and is required for HDV assembly (1, 30, 34) . Both forms are phosphoproteins (2, 15) , but the large form is more heavily phosphorylated than the small form (15) . LHDAg also contains a Cxxx box (where x is any amino acid) at its C terminus, in which the cysteine residue is isoprenylated (8, 15) . Recently, it has been demonstrated that LHDAg interacts with hepatitis B virus major surface antigen (HBsAg) through the prenylate residues (14) and that these prenylates are necessary, but not sufficient, for virion assembly (19) . Since both forms of HDAg are, for the most part, alike in sequence, the question of how these two proteins effect different func-(213) 342-9555. tions arises. Our previous studies have demonstrated that both forms can form homo-and heterodimers (39) and that proteinprotein interaction is required for the trans-activating function of SHDAg and the trans-dominant negative function of LHDAg (39) . Thus, a model has been proposed in which SHDAg complex is required for HDV RNA replication'and the LHDAg-SHDAg complex is not functional (39) . This model is based on the assumption that the two forms have different protein conformations. Indeed, we have obtained a monoclonal antibody (MAb) which recognizes an epitope at the C terminus of SHDAg that is not present in LHDAg (13) . Therefore, the C-terminal 19 amino acids of LHDAg likely alter the protein conformation of the HDAg, such that this epitope is not exposed. Since the C terminus of LHDAg is prenylated, which is known to increase the hydrophobicity of protein (6, 26) , the prenylate may play a central role in maintaining the protein conformation and biological activity of LHDAg.
Prenylation has been implicated in various protein functions. It occurs posttranslationally in many eukaryotic proteins and is usually followed by proteolysis and methylation at the C terminus of proteins (6, 29) . Prenylation promotes proteinprotein interactions to facilitate membrane localization of proteins (11, 12, 26) and function in signaling pathways (27, 28) .
To study the molecular basis of the different functions of the two HDAgs, we examined the effects of prenylation of LHDAg. We demonstrate that prenylates mask a conformational epitope at the C terminus of the protein either directly or as a result of the alteration of protein conformation. As a consequence, the prenylated LHDAg exhibits trans-dominant inhibitory activity. This study confirms the importance of protein conformation as the basis of HDAg functions and provides an insight into the effect of protein prenylation.
MATERIALS AND METHODS
Cells and cell culture. The monkey kidney cell lines Cos 7 (10) and H189, which is a Cos cell line with an integrated HDV trimer cDNA (22) polyacrylamide gel. The dried gel was exposed for autoradiography.
In vitro transcription. 32P-labeled HDV antigenomic RNA was synthesized by using 1 ,ug of HindIll-linearized plasmid S18, which contains a monomeric HDV cDNA behind the T7 promoter (39) . Transcription was performed with T7 RNA polymerase and [a-32P]UTP (3,000 Ci/mmol; ICN) as described previously (22) . The transcribed RNAs were purified by passage through a G-25 column (5 Prime->3 Prime, Inc.) and heat denatured before use.
Northern blot analysis. Total cellular RNA was extracted from the transfected Cos 7 cells at day 5 posttransfection, using the guanidinium isothiocyanate method (5). The RNA samples were electrophoresed in formaldehyde-containing agarose gels and transferred onto a nitrocellulose membrane (Hybond C; Amersham) overnight. The membrane was baked for 2 h at 80°C, prehybridized for 6 h, and hybridized with 32P-labeled HDV antigenomic RNA overnight at 55°C. The blots were washed briefly twice at room temperature and four times for 20 min each time at 80°C as previously reported (23) . HDV RNA extracted from the cell line H189 (22) (8, 14) . Another mutant, 192C, contains the isoprenylation motif CRPQ, which replaces the last four amino acids (QGFP) of SHDAg; this mutant SHDAg has been shown to be prenylated (14) . These mutant plasmids were transfected into Cos cells, and the radiolabeled proteins were immunoprecipitated with either rabbit polyclonal anti-HDAg serum or MAb 9E4. As shown in Fig. 1 (Fig. 3) . Previous studies indicated that all mutants bearing a C-terminal CRPQ, regardless of the context of the upstream sequence, were prenylated, but those with SRPQ were not (14, 19) . These mutants were transfected into Cos cells and precipitated with polyclonal or monoclonal antibodies. As shown in Fig. 4A , all constructs expressed similar levels of proteins, and all of them were precipitated by the polyclonal antibody against HDAg. The size differences among these mutant proteins are not evident in this gel; they are probably obscured by protein modifications and conformational differences. When these proteins were immunoprecipitated with MAb 9E4 (Fig. 4B) , all of the LHDAg mutants with a C-terminal SRPQ were precipitated, regardless of the length of amino acid deletions. In contrast, 9E4 did not precipitate any CRPQ-containing LHDAg mutants except 206C. This result further confirmed the importance of isoprenylation in masking the SHDAgspecific conformational epitope near the C terminus of HDAg. Without isoprenylation, this epitope is exposed. It is not clear why MAb 9E4 was able to precipitate the mutant LHDAg 206C. It is possible that the remaining 10 amino acids present a steric hindrance and prevent the prenylates from coming into contact with the 9E4-specific epitope. As expected, neither 192C nor 192S was precipitated by MAb 9E4, because of the alteration of the primary sequence of SHDAg. Effects of amino acid sequence deletion on the trans-dominant suppressor activity of LHDAg. We next examined whether C-terminal amino acid sequences of the LHDAg mutants and the state of isoprenylation are correlated with their abilities to inhibit HDV RNA replication. As demonstrated in Fig. 5 , most of the mutant HDAgs which have an isoprenylation motif almost completely suppressed HDV RNA replication. The only exception was 196C, which had a slightly lower inhibitory activity. Even 192C, which contains an isoprenylation motif replacing the C-terminal amino acids of SHDAg, without additional amino acids, had a significant inhibitory function. In contrast, all of the nonprenylated mutants except 201S allowed significant levels of HDV RNA replication, indicating lower suppressor activities. Overall, all of the prenylated HDAg mutants suppressed HDV RNA replication to a much higher extent than the corresponding nonprenylated mutants. However, there is no obvious correlation between inhibitory activity and length of amino acid deletion. These results are consistent with the previous interpretation (39) (17) . Since the 9E4-specific epitope, a structural feature unique to SHDAg, is affected by the state of prenylation, we determined whether the removal of prenylation signals would allow LHDAg to serve as a trans activator. To address this possibility, Cos 7 cells were cotransfected with either wild-type or mutant HDAgs and Smd2, a replication-defective HDV dimer (20, 39) containing a frameshift mutation in the HDAg open reading frame, and the ability of any mutant HDAg to complement the defect of HDV RNA replication was examined. As shown in Fig. 6 , Smd2 was unable to replicate by itself. However, in the presence of wild-type SHDAg, this mutant dimer could replicate. Interestingly, 192S, which is an SHDAg mutant containing a defective isoprenylation motif, still retained a partial trans-activating activity. In contrast, a comparable mutant, 192C, which is prenylated (14, 20) , lost all trans-activating activity, suggesting that isoprenylation is a major factor affecting the trans-activating activity. Although most of the LHDAg mutants could not trans activate, a prenylation-defective mutant, 211S, which retained all of the 19 amino acids (except cysteine) unique to wild-type LHDAg, had the ability to complement the replication function partially. From these observations, we conclude that isoprenylation and other amino acid residues are responsible for altering the protein conformation of HDAg such that LHDAg and other HDAg mutants lost the trans-activating activity.
The biological properties of all the HDAg mutants are summarized in Fig. 3 . 
DISCUSSION
Both SHDAg and LHDAg share many structural characteristics and functional domains, including the coiled-coil sequence (39) , nuclear localization signal (40) , and RNA-binding motifs (20) . However, the extra 19 amino acids at the C terminus of LHDAg cause a dramatic difference between these two HDAgs in their function in HDV RNA replication as well as HDV assembly. The last 19 amino acids contain an isoprenylation site and may be phosphorylated as well, since these amino acids include two serines, which are targets for phosphorylation (2), and LHDAg is more heavily phosphorylated than SHDAg (15 (14) and is involved in HDV virion assembly (1, 30, 34) . This protein-protein interaction is mediated through the prenylate residues within the C-terminal 19 amino acids (14) and appears to be the basis of HDV virion assembly, since the prenylation-defective mutant LHDAgs cannot interact with HBsAg (14) and cannot be packaged (19) . There are two possible mechanisms to explain the role of prenylation in HDAg-HBsAg interactions: the protein-protein interaction may be mediated directly through prenylates, or prenylation may alter HDAg conformation to allow other parts of HDAg to interact with HBsAg. These two possibilities are not mutually exclusive. Indeed, our previous studies indicate that both the prenylate and the 19 amino acids are required for HDAg-HBsAg interaction (14) and HDV virion packaging (19) . Our current study further revealed that prenylates mask a unique conformational epitope of the C-terminal region of HDAg. The masking of this epitope can be mediated either directly by the prenylates or indirectly through protein conformational changes induced by prenylation. We cannot distinguish between these two possibilities. Nevertheless, we can conclude that prenylation not only increases protein hydrophobicity to target proteins to the membrane as previously thought (6, 26) but also changes overall conformation of the protein so as to facilitate its interaction with other proteins.
The second unique biological activity of LHDAg is its trans-dominant inhibiting activity on HDV RNA replication. Intuitively, the C-terminal 19 amino acids of LHDAg may be considered an inhibitory sequence. However, our previous results with use of mutant HDAgs which fail to dimerize suggest that the inhibitory activity is more likely due to the conformational differences between the LHDAg and SHDAg (39) . Furthermore, the inhibitory activity of LHDAg has been shown to be quite variable and unpredictable with respect to the length and sequence of the C-terminal amino acids (9) , making the possibility of inhibitory sequence less likely. Our results here clearly demonstrate that the prenylate plays a major role in the trans-dominant inhibitory activity of LHDAg. This conclusion was supported by the finding that the prenylated mutant in every pair of HDAg deletion mutants invariably had a much stronger inhibitory activity than its nonprenylated counterpart. Furthermore, an SHDAg mutant in which the last four amino acids were replaced with CRPQ while maintaining the same length as in wild-type SHDAg inhibited HDV RNA replication as efficiently as LHDAg, suggesting that isoprenylation alone can exert inhibitory activity. Nevertheless, some combinations of C-terminal amino acid sequences may also alter protein conformation such that some LHDAg mutants without an isoprenylation signal may confer partial inhibition.
SHDAg contains a unique activity, i.e., trans activation of 
